 | • レポートコード：MRC2-11QY01797 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は静脈内免疫グロブリンのグローバル市場について調査・分析したレポートです。種類別（神経学静脈内免疫グロブリン、血液学静脈内免疫グロブリン、免疫学静脈内免疫グロブリン）市場規模、用途別（原発性免疫不全症、特発性血小板減少性紫斑病、慢性炎症性脱髄性多発神経障害、川崎病、ギランバレー症候群）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別静脈内免疫グロブリンの競争状況、市場シェア ・世界の静脈内免疫グロブリン市場：種類別市場規模 2015年-2020年（神経学静脈内免疫グロブリン、血液学静脈内免疫グロブリン、免疫学静脈内免疫グロブリン） ・世界の静脈内免疫グロブリン市場：種類別市場規模予測 2021年-2026年（神経学静脈内免疫グロブリン、血液学静脈内免疫グロブリン、免疫学静脈内免疫グロブリン） ・世界の静脈内免疫グロブリン市場：用途別市場規模 2015年-2020年（原発性免疫不全症、特発性血小板減少性紫斑病、慢性炎症性脱髄性多発神経障害、川崎病、ギランバレー症候群） ・世界の静脈内免疫グロブリン市場：用途別市場規模予測 2021年-2026年（原発性免疫不全症、特発性血小板減少性紫斑病、慢性炎症性脱髄性多発神経障害、川崎病、ギランバレー症候群） ・北米の静脈内免疫グロブリン市場分析：米国、カナダ ・ヨーロッパの静脈内免疫グロブリン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの静脈内免疫グロブリン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の静脈内免疫グロブリン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの静脈内免疫グロブリン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CSL Behring、Grifols、Octapharma、Takeda、ADMA Biologics、Bayer、Bharat Serum and Vaccines、Biotest、China Biologic Products、Hualan Biological Engineering、Kedrion Biopharma、LFB Group、Sanquin ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Immunoglobulin therapy is the use of a mixture of antibodies (immunoglobulins) to treat a number of health conditions. These conditions include primary immunodeficiency, idiopathic thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain-Barré syndrome, and in certain other infections when a more specific immunoglobulin is not available. Depending on the formulation it can be given by injection into muscle, a vein, or under the skin.
Intravenous formulations began to be approved in the 1980s, which represented a significant improvement over intramuscular objections, as they allowed for a sufficient amount of immunoglobulin to be injected to reach clinical efficacy, although they still had a fairly high rate of adverse effects.
Market Analysis and Insights: Global Intravenous Immunoglobulins Market
The global Intravenous Immunoglobulins market size is projected to reach US$ 9735.3 million by 2026, from US$ 9152.2 million in 2020, at a CAGR of 5.9%% during 2021-2026.
Global Intravenous Immunoglobulins Scope and Market Size
Intravenous Immunoglobulins market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous Immunoglobulins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Intravenous Immunoglobulins market is segmented into
Neurology Intravenous Immunoglobulins
Hematology Intravenous Immunoglobulins
Immunology Intravenous Immunoglobulins
Segment by Application, the Intravenous Immunoglobulins market is segmented into
Primary Immunodeficiency
Idiopathic Thrombocytopenic Purpura
Chronic Inflammatory Demyelinating Polyneuropathy
Kawasaki Disease
Guillain-Barre Syndrome
Regional and Country-level Analysis
The Intravenous Immunoglobulins market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intravenous Immunoglobulins market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Intravenous Immunoglobulins Market Share Analysis
Intravenous Immunoglobulins market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravenous Immunoglobulins business, the date to enter into the Intravenous Immunoglobulins market, Intravenous Immunoglobulins product introduction, recent developments, etc.
The major vendors covered:
CSL Behring
Grifols
Octapharma
Takeda
ADMA Biologics
Bayer
Bharat Serum and Vaccines
Biotest
China Biologic Products
Hualan Biological Engineering
Kedrion Biopharma
LFB Group
Sanquin
1 Study Coverage
1.1 Intravenous Immunoglobulins Product Introduction
1.2 Market Segments
1.3 Key Intravenous Immunoglobulins Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Intravenous Immunoglobulins Market Size Growth Rate by Type
1.4.2 Neurology Intravenous Immunoglobulins
1.4.3 Hematology Intravenous Immunoglobulins
1.4.4 Immunology Intravenous Immunoglobulins
1.5 Market by Application
1.5.1 Global Intravenous Immunoglobulins Market Size Growth Rate by Application
1.5.2 Primary Immunodeficiency
1.5.3 Idiopathic Thrombocytopenic Purpura
1.5.4 Chronic Inflammatory Demyelinating Polyneuropathy
1.5.5 Kawasaki Disease
1.5.6 Guillain-Barre Syndrome
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Intravenous Immunoglobulins Market Size, Estimates and Forecasts
2.1.1 Global Intravenous Immunoglobulins Revenue 2015-2026
2.1.2 Global Intravenous Immunoglobulins Sales 2015-2026
2.2 Global Intravenous Immunoglobulins, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Intravenous Immunoglobulins Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Intravenous Immunoglobulins Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Intravenous Immunoglobulins Competitor Landscape by Players
3.1 Intravenous Immunoglobulins Sales by Manufacturers
3.1.1 Intravenous Immunoglobulins Sales by Manufacturers (2015-2020)
3.1.2 Intravenous Immunoglobulins Sales Market Share by Manufacturers (2015-2020)
3.2 Intravenous Immunoglobulins Revenue by Manufacturers
3.2.1 Intravenous Immunoglobulins Revenue by Manufacturers (2015-2020)
3.2.2 Intravenous Immunoglobulins Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intravenous Immunoglobulins Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Intravenous Immunoglobulins Revenue in 2019
3.2.5 Global Intravenous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Intravenous Immunoglobulins Price by Manufacturers
3.4 Intravenous Immunoglobulins Manufacturing Base Distribution, Product Types
3.4.1 Intravenous Immunoglobulins Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravenous Immunoglobulins Product Type
3.4.3 Date of International Manufacturers Enter into Intravenous Immunoglobulins Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Intravenous Immunoglobulins Market Size by Type (2015-2020)
4.1.1 Global Intravenous Immunoglobulins Sales by Type (2015-2020)
4.1.2 Global Intravenous Immunoglobulins Revenue by Type (2015-2020)
4.1.3 Intravenous Immunoglobulins Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Intravenous Immunoglobulins Market Size Forecast by Type (2021-2026)
4.2.1 Global Intravenous Immunoglobulins Sales Forecast by Type (2021-2026)
4.2.2 Global Intravenous Immunoglobulins Revenue Forecast by Type (2021-2026)
4.2.3 Intravenous Immunoglobulins Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Intravenous Immunoglobulins Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Intravenous Immunoglobulins Market Size by Application (2015-2020)
5.1.1 Global Intravenous Immunoglobulins Sales by Application (2015-2020)
5.1.2 Global Intravenous Immunoglobulins Revenue by Application (2015-2020)
5.1.3 Intravenous Immunoglobulins Price by Application (2015-2020)
5.2 Intravenous Immunoglobulins Market Size Forecast by Application (2021-2026)
5.2.1 Global Intravenous Immunoglobulins Sales Forecast by Application (2021-2026)
5.2.2 Global Intravenous Immunoglobulins Revenue Forecast by Application (2021-2026)
5.2.3 Global Intravenous Immunoglobulins Price Forecast by Application (2021-2026)
6 North America
6.1 North America Intravenous Immunoglobulins by Country
6.1.1 North America Intravenous Immunoglobulins Sales by Country
6.1.2 North America Intravenous Immunoglobulins Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Intravenous Immunoglobulins Market Facts & Figures by Type
6.3 North America Intravenous Immunoglobulins Market Facts & Figures by Application
7 Europe
7.1 Europe Intravenous Immunoglobulins by Country
7.1.1 Europe Intravenous Immunoglobulins Sales by Country
7.1.2 Europe Intravenous Immunoglobulins Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravenous Immunoglobulins Market Facts & Figures by Type
7.3 Europe Intravenous Immunoglobulins Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Intravenous Immunoglobulins by Region
8.1.1 Asia Pacific Intravenous Immunoglobulins Sales by Region
8.1.2 Asia Pacific Intravenous Immunoglobulins Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Intravenous Immunoglobulins Market Facts & Figures by Type
8.3 Asia Pacific Intravenous Immunoglobulins Market Facts & Figures by Application
9 Latin America
9.1 Latin America Intravenous Immunoglobulins by Country
9.1.1 Latin America Intravenous Immunoglobulins Sales by Country
9.1.2 Latin America Intravenous Immunoglobulins Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Intravenous Immunoglobulins Market Facts & Figures by Type
9.3 Central & South America Intravenous Immunoglobulins Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Intravenous Immunoglobulins by Country
10.1.1 Middle East and Africa Intravenous Immunoglobulins Sales by Country
10.1.2 Middle East and Africa Intravenous Immunoglobulins Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Intravenous Immunoglobulins Market Facts & Figures by Type
10.3 Middle East and Africa Intravenous Immunoglobulins Market Facts & Figures by Application
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Description and Business Overview
11.1.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Behring Intravenous Immunoglobulins Products Offered
11.1.5 CSL Behring Related Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Description and Business Overview
11.2.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Grifols Intravenous Immunoglobulins Products Offered
11.2.5 Grifols Related Developments
11.3 Octapharma
11.3.1 Octapharma Corporation Information
11.3.2 Octapharma Description and Business Overview
11.3.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Octapharma Intravenous Immunoglobulins Products Offered
11.3.5 Octapharma Related Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Description and Business Overview
11.4.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Takeda Intravenous Immunoglobulins Products Offered
11.4.5 Takeda Related Developments
11.5 ADMA Biologics
11.5.1 ADMA Biologics Corporation Information
11.5.2 ADMA Biologics Description and Business Overview
11.5.3 ADMA Biologics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 ADMA Biologics Intravenous Immunoglobulins Products Offered
11.5.5 ADMA Biologics Related Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Description and Business Overview
11.6.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bayer Intravenous Immunoglobulins Products Offered
11.6.5 Bayer Related Developments
11.7 Bharat Serum and Vaccines
11.7.1 Bharat Serum and Vaccines Corporation Information
11.7.2 Bharat Serum and Vaccines Description and Business Overview
11.7.3 Bharat Serum and Vaccines Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bharat Serum and Vaccines Intravenous Immunoglobulins Products Offered
11.7.5 Bharat Serum and Vaccines Related Developments
11.8 Biotest
11.8.1 Biotest Corporation Information
11.8.2 Biotest Description and Business Overview
11.8.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biotest Intravenous Immunoglobulins Products Offered
11.8.5 Biotest Related Developments
11.9 China Biologic Products
11.9.1 China Biologic Products Corporation Information
11.9.2 China Biologic Products Description and Business Overview
11.9.3 China Biologic Products Sales, Revenue and Gross Margin (2015-2020)
11.9.4 China Biologic Products Intravenous Immunoglobulins Products Offered
11.9.5 China Biologic Products Related Developments
11.10 Hualan Biological Engineering
11.10.1 Hualan Biological Engineering Corporation Information
11.10.2 Hualan Biological Engineering Description and Business Overview
11.10.3 Hualan Biological Engineering Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hualan Biological Engineering Intravenous Immunoglobulins Products Offered
11.10.5 Hualan Biological Engineering Related Developments
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Description and Business Overview
11.1.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL Behring Intravenous Immunoglobulins Products Offered
11.1.5 CSL Behring Related Developments
11.12 LFB Group
11.12.1 LFB Group Corporation Information
11.12.2 LFB Group Description and Business Overview
11.12.3 LFB Group Sales, Revenue and Gross Margin (2015-2020)
11.12.4 LFB Group Products Offered
11.12.5 LFB Group Related Developments
11.13 Sanquin
11.13.1 Sanquin Corporation Information
11.13.2 Sanquin Description and Business Overview
11.13.3 Sanquin Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sanquin Products Offered
11.13.5 Sanquin Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Intravenous Immunoglobulins Market Estimates and Projections by Region
12.1.1 Global Intravenous Immunoglobulins Sales Forecast by Regions 2021-2026
12.1.2 Global Intravenous Immunoglobulins Revenue Forecast by Regions 2021-2026
12.2 North America Intravenous Immunoglobulins Market Size Forecast (2021-2026)
12.2.1 North America: Intravenous Immunoglobulins Sales Forecast (2021-2026)
12.2.2 North America: Intravenous Immunoglobulins Revenue Forecast (2021-2026)
12.2.3 North America: Intravenous Immunoglobulins Market Size Forecast by Country (2021-2026)
12.3 Europe Intravenous Immunoglobulins Market Size Forecast (2021-2026)
12.3.1 Europe: Intravenous Immunoglobulins Sales Forecast (2021-2026)
12.3.2 Europe: Intravenous Immunoglobulins Revenue Forecast (2021-2026)
12.3.3 Europe: Intravenous Immunoglobulins Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Intravenous Immunoglobulins Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Intravenous Immunoglobulins Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Intravenous Immunoglobulins Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Intravenous Immunoglobulins Market Size Forecast by Region (2021-2026)
12.5 Latin America Intravenous Immunoglobulins Market Size Forecast (2021-2026)
12.5.1 Latin America: Intravenous Immunoglobulins Sales Forecast (2021-2026)
12.5.2 Latin America: Intravenous Immunoglobulins Revenue Forecast (2021-2026)
12.5.3 Latin America: Intravenous Immunoglobulins Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Intravenous Immunoglobulins Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Intravenous Immunoglobulins Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Intravenous Immunoglobulins Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Intravenous Immunoglobulins Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Intravenous Immunoglobulins Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Intravenous Immunoglobulins Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Intravenous Immunoglobulins Market Segments
Table 2. Ranking of Global Top Intravenous Immunoglobulins Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intravenous Immunoglobulins Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Neurology Intravenous Immunoglobulins
Table 5. Major Manufacturers of Hematology Intravenous Immunoglobulins
Table 6. Major Manufacturers of Immunology Intravenous Immunoglobulins
Table 7. Global Intravenous Immunoglobulins Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Intravenous Immunoglobulins Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Intravenous Immunoglobulins Sales by Regions 2015-2020 (K Units)
Table 10. Global Intravenous Immunoglobulins Sales Market Share by Regions (2015-2020)
Table 11. Global Intravenous Immunoglobulins Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Intravenous Immunoglobulins Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Intravenous Immunoglobulins Sales Share by Manufacturers (2015-2020)
Table 14. Global Intravenous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Intravenous Immunoglobulins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulins as of 2019)
Table 16. Intravenous Immunoglobulins Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Intravenous Immunoglobulins Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Intravenous Immunoglobulins Price (2015-2020) (USD/Unit)
Table 19. Intravenous Immunoglobulins Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Intravenous Immunoglobulins Product Type
Table 21. Date of International Manufacturers Enter into Intravenous Immunoglobulins Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Intravenous Immunoglobulins Sales by Type (2015-2020) (K Units)
Table 24. Global Intravenous Immunoglobulins Sales Share by Type (2015-2020)
Table 25. Global Intravenous Immunoglobulins Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Intravenous Immunoglobulins Revenue Share by Type (2015-2020)
Table 27. Intravenous Immunoglobulins Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Intravenous Immunoglobulins Sales by Application (2015-2020) (K Units)
Table 29. Global Intravenous Immunoglobulins Sales Share by Application (2015-2020)
Table 30. North America Intravenous Immunoglobulins Sales by Country (2015-2020) (K Units)
Table 31. North America Intravenous Immunoglobulins Sales Market Share by Country (2015-2020)
Table 32. North America Intravenous Immunoglobulins Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Intravenous Immunoglobulins Revenue Market Share by Country (2015-2020)
Table 34. North America Intravenous Immunoglobulins Sales by Type (2015-2020) (K Units)
Table 35. North America Intravenous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 36. North America Intravenous Immunoglobulins Sales by Application (2015-2020) (K Units)
Table 37. North America Intravenous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 38. Europe Intravenous Immunoglobulins Sales by Country (2015-2020) (K Units)
Table 39. Europe Intravenous Immunoglobulins Sales Market Share by Country (2015-2020)
Table 40. Europe Intravenous Immunoglobulins Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Intravenous Immunoglobulins Revenue Market Share by Country (2015-2020)
Table 42. Europe Intravenous Immunoglobulins Sales by Type (2015-2020) (K Units)
Table 43. Europe Intravenous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 44. Europe Intravenous Immunoglobulins Sales by Application (2015-2020) (K Units)
Table 45. Europe Intravenous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Intravenous Immunoglobulins Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Intravenous Immunoglobulins Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Intravenous Immunoglobulins Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Intravenous Immunoglobulins Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Intravenous Immunoglobulins Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Intravenous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Intravenous Immunoglobulins Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Intravenous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 54. Latin America Intravenous Immunoglobulins Sales by Country (2015-2020) (K Units)
Table 55. Latin America Intravenous Immunoglobulins Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Intravenous Immunoglobulins Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Intravenous Immunoglobulins Revenue Market Share by Country (2015-2020)
Table 58. Latin America Intravenous Immunoglobulins Sales by Type (2015-2020) (K Units)
Table 59. Latin America Intravenous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 60. Latin America Intravenous Immunoglobulins Sales by Application (2015-2020) (K Units)
Table 61. Latin America Intravenous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Intravenous Immunoglobulins Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Intravenous Immunoglobulins Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Intravenous Immunoglobulins Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Intravenous Immunoglobulins Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Intravenous Immunoglobulins Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Application (2015-2020)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Major Businesses
Table 72. CSL Behring Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. CSL Behring Product
Table 74. CSL Behring Recent Development
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Major Businesses
Table 77. Grifols Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Grifols Product
Table 79. Grifols Recent Development
Table 80. Octapharma Corporation Information
Table 81. Octapharma Description and Major Businesses
Table 82. Octapharma Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Octapharma Product
Table 84. Octapharma Recent Development
Table 85. Takeda Corporation Information
Table 86. Takeda Description and Major Businesses
Table 87. Takeda Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Takeda Product
Table 89. Takeda Recent Development
Table 90. ADMA Biologics Corporation Information
Table 91. ADMA Biologics Description and Major Businesses
Table 92. ADMA Biologics Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. ADMA Biologics Product
Table 94. ADMA Biologics Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Major Businesses
Table 97. Bayer Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bayer Product
Table 99. Bayer Recent Development
Table 100. Bharat Serum and Vaccines Corporation Information
Table 101. Bharat Serum and Vaccines Description and Major Businesses
Table 102. Bharat Serum and Vaccines Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bharat Serum and Vaccines Product
Table 104. Bharat Serum and Vaccines Recent Development
Table 105. Biotest Corporation Information
Table 106. Biotest Description and Major Businesses
Table 107. Biotest Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Biotest Product
Table 109. Biotest Recent Development
Table 110. China Biologic Products Corporation Information
Table 111. China Biologic Products Description and Major Businesses
Table 112. China Biologic Products Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. China Biologic Products Product
Table 114. China Biologic Products Recent Development
Table 115. Hualan Biological Engineering Corporation Information
Table 116. Hualan Biological Engineering Description and Major Businesses
Table 117. Hualan Biological Engineering Intravenous Immunoglobulins Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Hualan Biological Engineering Product
Table 119. Hualan Biological Engineering Recent Development
Table 120. Kedrion Biopharma Corporation Information
Table 121. Kedrion Biopharma Description and Major Businesses
Table 122. Kedrion Biopharma Intravenous Immunoglobulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Kedrion Biopharma Product
Table 124. Kedrion Biopharma Recent Development
Table 125. LFB Group Corporation Information
Table 126. LFB Group Description and Major Businesses
Table 127. LFB Group Intravenous Immunoglobulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. LFB Group Product
Table 129. LFB Group Recent Development
Table 130. Sanquin Corporation Information
Table 131. Sanquin Description and Major Businesses
Table 132. Sanquin Intravenous Immunoglobulins Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Sanquin Product
Table 134. Sanquin Recent Development
Table 135. Global Intravenous Immunoglobulins Sales Forecast by Regions (2021-2026) (K Units)
Table 136. Global Intravenous Immunoglobulins Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Intravenous Immunoglobulins Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Intravenous Immunoglobulins Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Intravenous Immunoglobulins Sales Forecast by Country (2021-2026) (K Units)
Table 140. North America: Intravenous Immunoglobulins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Intravenous Immunoglobulins Sales Forecast by Country (2021-2026) (K Units)
Table 142. Europe: Intravenous Immunoglobulins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Intravenous Immunoglobulins Sales Forecast by Region (2021-2026) (K Units)
Table 144. Asia Pacific: Intravenous Immunoglobulins Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Intravenous Immunoglobulins Sales Forecast by Country (2021-2026) (K Units)
Table 146. Latin America: Intravenous Immunoglobulins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Intravenous Immunoglobulins Sales Forecast by Country (2021-2026) (K Units)
Table 148. Middle East and Africa: Intravenous Immunoglobulins Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Intravenous Immunoglobulins Players
Table 153. Intravenous Immunoglobulins Customers List
Table 154. Intravenous Immunoglobulins Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Immunoglobulins Product Picture
Figure 2. Global Intravenous Immunoglobulins Sales Market Share by Type in 2020 & 2026
Figure 3. Neurology Intravenous Immunoglobulins Product Picture
Figure 4. Hematology Intravenous Immunoglobulins Product Picture
Figure 5. Immunology Intravenous Immunoglobulins Product Picture
Figure 6. Global Intravenous Immunoglobulins Sales Market Share by Application in 2020 & 2026
Figure 7. Primary Immunodeficiency
Figure 8. Idiopathic Thrombocytopenic Purpura
Figure 9. Chronic Inflammatory Demyelinating Polyneuropathy
Figure 10. Kawasaki Disease
Figure 11. Guillain-Barre Syndrome
Figure 12. Intravenous Immunoglobulins Report Years Considered
Figure 13. Global Intravenous Immunoglobulins Market Size 2015-2026 (US$ Million)
Figure 14. Global Intravenous Immunoglobulins Sales 2015-2026 (K Units)
Figure 15. Global Intravenous Immunoglobulins Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Intravenous Immunoglobulins Sales Market Share by Region (2015-2020)
Figure 17. Global Intravenous Immunoglobulins Sales Market Share by Region in 2019
Figure 18. Global Intravenous Immunoglobulins Revenue Market Share by Region (2015-2020)
Figure 19. Global Intravenous Immunoglobulins Revenue Market Share by Region in 2019
Figure 20. Global Intravenous Immunoglobulins Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Intravenous Immunoglobulins Revenue in 2019
Figure 22. Intravenous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Intravenous Immunoglobulins Sales Market Share by Type (2015-2020)
Figure 24. Global Intravenous Immunoglobulins Sales Market Share by Type in 2019
Figure 25. Global Intravenous Immunoglobulins Revenue Market Share by Type (2015-2020)
Figure 26. Global Intravenous Immunoglobulins Revenue Market Share by Type in 2019
Figure 27. Global Intravenous Immunoglobulins Market Share by Price Range (2015-2020)
Figure 28. Global Intravenous Immunoglobulins Sales Market Share by Application (2015-2020)
Figure 29. Global Intravenous Immunoglobulins Sales Market Share by Application in 2019
Figure 30. Global Intravenous Immunoglobulins Revenue Market Share by Application (2015-2020)
Figure 31. Global Intravenous Immunoglobulins Revenue Market Share by Application in 2019
Figure 32. North America Intravenous Immunoglobulins Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Intravenous Immunoglobulins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Intravenous Immunoglobulins Sales Market Share by Country in 2019
Figure 35. North America Intravenous Immunoglobulins Revenue Market Share by Country in 2019
Figure 36. U.S. Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Intravenous Immunoglobulins Market Share by Type in 2019
Figure 41. North America Intravenous Immunoglobulins Market Share by Application in 2019
Figure 42. Europe Intravenous Immunoglobulins Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Intravenous Immunoglobulins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Intravenous Immunoglobulins Sales Market Share by Country in 2019
Figure 45. Europe Intravenous Immunoglobulins Revenue Market Share by Country in 2019
Figure 46. Germany Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Intravenous Immunoglobulins Market Share by Type in 2019
Figure 57. Europe Intravenous Immunoglobulins Market Share by Application in 2019
Figure 58. Asia Pacific Intravenous Immunoglobulins Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Intravenous Immunoglobulins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Intravenous Immunoglobulins Sales Market Share by Region in 2019
Figure 61. Asia Pacific Intravenous Immunoglobulins Revenue Market Share by Region in 2019
Figure 62. China Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Intravenous Immunoglobulins Market Share by Type in 2019
Figure 85. Asia Pacific Intravenous Immunoglobulins Market Share by Application in 2019
Figure 86. Latin America Intravenous Immunoglobulins Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Intravenous Immunoglobulins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Intravenous Immunoglobulins Sales Market Share by Country in 2019
Figure 89. Latin America Intravenous Immunoglobulins Revenue Market Share by Country in 2019
Figure 90. Mexico Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Intravenous Immunoglobulins Market Share by Type in 2019
Figure 97. Latin America Intravenous Immunoglobulins Market Share by Application in 2019
Figure 98. Middle East and Africa Intravenous Immunoglobulins Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Intravenous Immunoglobulins Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Intravenous Immunoglobulins Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Intravenous Immunoglobulins Revenue Market Share by Country in 2019
Figure 102. Turkey Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Intravenous Immunoglobulins Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Intravenous Immunoglobulins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Intravenous Immunoglobulins Market Share by Type in 2019
Figure 109. Middle East and Africa Intravenous Immunoglobulins Market Share by Application in 2019
Figure 110. North America Intravenous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Intravenous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Intravenous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Intravenous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Intravenous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Intravenous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Intravenous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Intravenous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Intravenous Immunoglobulins Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Intravenous Immunoglobulins Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
静脈内（IV）溶液の世界市場（～2026年） Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products …- 静脈内鉄薬の世界市場（～2026年） Iron is an essential element as it plays an important role in many vital biological processes such as the synthesis of heme which forms the basis of hemoglobin (Hb) the oxygen-carrying protein of the blood, the formation of myoglobin, energy metabolism, neurotransmitter production, the formation of …
- プラズマ治療薬の世界市場（～2026年） Plasma, pale yellow in color, is the component of the blood. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI. M…
- 鳥インフルエンザ治療の世界市場（～2026年） Bird flu is a viral infection caused by avian influenza A viruses in birds. The viruses that cause the disease in birds can mutate and spread to humans. Bird flu is named H or N depending on the protein found on the surface of the virus. Out of the three types of influenza viruses (A, B, and C), inf…
- ムコ多糖症（MPS）遺伝子治療の世界市場（～2026年） Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …